Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial
Osteoarthritis, Knee
About this trial
This is an interventional treatment trial for Osteoarthritis, Knee
Eligibility Criteria
Inclusion Criteria: Adult males and females aged 20 to 75 years Kellgren-Lawrence (KL) grade 1 to 3 Individuals who voluntarily decide to participate in the study and provide written informed consent form Individuals who can understand and follow instructions and can participate in the study during the entire study period Exclusion Criteria: Individuals who have clear secondary osteoarthritis caused by inflammatory, infectious, metabolic arthritis, or other conditions such as rheumatoid arthritis, rather than primary knee osteoarthritis as determined by the investigator Individuals with other factors that could potentially affect the assessment of this clinical study due to pain caused by osteoarthritis or other conditions in the hip joint Individuals who have undergone knee joint arthroplasty Individuals who have undergone open knee surgery (ligament reconstruction, osteotomy) within 3 years prior to the screening visit
Sites / Locations
- Asan Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
SKCPT group
Celebrex group